Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Oligoastrocytoma
ADR ID BADD_A10553
ADR Hierarchy
17      Nervous system disorders
17.20      Nervous system neoplasms malignant and unspecified NEC
17.20.02      Glial tumours malignant
17.20.02.011      Oligoastrocytoma
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.30      Nervous system neoplasms malignant and unspecified NEC
16.30.02      Glial tumours malignant
16.30.02.011      Oligoastrocytoma
Description Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21) [MeSH]
MedDRA Code 10073131
MeSH ID D005910
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Mixed astrocytoma-ependymoma | Mixed astrocytoma-oligodendroglioma | Mixed oligo-astrocytoma | Oligoastrocytoma | Mixed glioma | Glioma | Gliomas | Glial Cell Tumors | Glial Cell Tumor | Tumor, Glial Cell | Tumors, Glial Cell | Mixed Glioma | Glioma, Mixed | Gliomas, Mixed | Mixed Gliomas | Malignant Glioma | Glioma, Malignant | Gliomas, Malignant | Malignant Gliomas
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02150Temozolomide0.000112%
The 1th Page    1    Total 1 Pages